Sarepta Therapeutics Inc Stock Ownership - Who owns Sarepta Therapeutics?

Insider buying vs selling

Have Sarepta Therapeutics Inc insiders been buying or selling?
Ryan Edward BrownEVP General Counsel2023-06-0189$123.60
Bilal ArifChief Tech Ops Officer2023-03-30307$136.66
Bilal ArifChief Tech Ops Officer2023-03-08314$153.19
Louise RodinoklapacHead of RD CSO2023-03-08912$153.19
Ian Michael EstepanChief Financial Officer2023-03-08744$153.19
Ryan Edward BrownSVP General Counsel2023-03-08635$153.19
Louise RodinoklapacHead of RD CSO2023-03-061,134$157.21
Bilal ArifChief Tech Ops Officer2023-03-06154$157.21
Ryan Edward BrownSVP General Counsel2023-03-06171$157.21
Ryan Edward BrownSVP General Counsel2023-03-061,154$157.21

1 of 3

SRPT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SRPT insiders and whales buy or sell their stock.

SRPT Shareholders

What type of owners hold Sarepta Therapeutics Inc stock?
Black Bear Offshore Master Fund LP10.64%9,914,211$1.27BInsider
Vanguard Group Inc8.71%8,112,964$1.04BInstitution
Eastbourne Capital Management LLC6.08%5,659,211$723.81MInsider
Blackrock Inc5.67%5,282,695$675.66MInstitution
Janus Henderson Group PLC5.27%4,908,204$627.76MInstitution
Jpmorgan Chase Co3.98%3,702,944$473.61MInstitution
Avoro Capital Advisors LLC3.92%3,650,000$466.84MInstitution
Richard Barry3.36%3,129,842$400.31MInsider
Ecor1 Capital LLC3.22%2,999,453$383.63MInstitution
Rockall Emerging Markets Master Fund Ltd3.15%2,935,696$375.48MInsider

1 of 3

SRPT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SRPT73.61%26.39%Net BuyingNet Selling
TECH93.31%2.14%Net BuyingNet Buying
UTHR87.71%12.29%Net SellingNet Selling
APLS74.31%25.69%Net BuyingNet Buying

Sarepta Therapeutics Stock Ownership FAQ

Who owns Sarepta Therapeutics?

Sarepta Therapeutics (NASDAQ: SRPT) is owned by 85.56% institutional shareholders, 30.67% Sarepta Therapeutics insiders, and 0.00% retail investors. Black Bear Offshore Master Fund LP is the largest individual Sarepta Therapeutics shareholder, owning 9.91M shares representing 10.64% of the company. Black Bear Offshore Master Fund LP's Sarepta Therapeutics shares are currently valued at $1.25B.

If you're new to stock investing, here's how to buy Sarepta Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.